Liver Cancer - Pipeline Review, H2 2015

Liver Cancer - Pipeline Review, H2 2015

Code: GMDHC7300IDB | Published: Dec-2015 | Pages: 1113 | Global Markets Direct
Price :
$2,500.00
USD

* Required Fields

$2,500.00

Details

Liver Cancer - Pipeline Review, H2 2015

Summary

Global Markets Directs, Liver Cancer - Pipeline Review, H2 2015, provides an overview of the Liver Cancers therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Liver Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Liver Cancer and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note
4SC AG
AB Science SA
AbbVie Inc.
Acceleron Pharma, Inc.
ACROVIS Pharma AG
Adaptimmune Limited
Aduro BioTech, Inc.
Advanced Accelerator Applications SA
Advenchen Laboratories, LLC
Alfact Innovation
Alnylam Pharmaceuticals, Inc.
American Gene Technologies International Inc.
Amgen Inc.
AndroScience Corporation
APAvadis Biotechnologies Srl
Arbutus Biopharma Corporation
ArQule, Inc.
Array BioPharma Inc.
Arrowhead Research Corporation
Astex Pharmaceuticals, Inc.
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Bayer AG
Bio-Cancer Treatment International Limited
BioCancell Ltd
Biogazelle
Bioneer Corporation
BioStar Pharmaceuticals, Inc.
Blueprint Medicines
Boehringer Ingelheim GmbH
Boston Biomedical, Inc.
Bristol-Myers Squibb Company
Caladrius Biosciences, Inc.
Can-Fite BioPharma Ltd.
CASI Pharmaceuticals Inc.
CCRP Therapeutics GmbH
Celgene Corporation
Celldex Therapeutics, Inc.
Celsion Corporation
China Medical System Holdings Limited
Chipscreen Biosciences Ltd
Chroma Therapeutics Limited
CohBar, Inc.
CrystalGenomics, Inc.
CytRx Corporation
CZ BioMed Corp
Delcath Systems, Inc.
Dicerna Pharmaceuticals, Inc.
Digna Biotech, S.L.
Double Bond Pharmaceutical International AB
e-Therapeutics Plc
Eisai Co., Ltd.
Eli Lilly and Company
Endocyte, Inc.
Erytech Pharma SA
Eureka Therapeutics, Inc.
Exelixis, Inc.
F. Hoffmann-La Roche Ltd.
Genelux Corporation
Genoscience Pharma
GenSpera, Inc.
GlaxoSmithKline Plc
Golden Biotechnology Corp.
HanAll Biopharma Co., Ltd.
HEC Pharm Co., Ltd.
Horizon Pharma Plc
Huperion Sarl
Immunicum AB
Immunitor, Inc.
Immunomedics, Inc.
Immunovative Therapies, Ltd.
Immuron Limited
IMPACT Therapeutics, Inc.
In-Cell-Art S.A.S.
Incanthera Ltd.
Incuron, LLC
InteRNA Technologies B.V.
Jasco Pharmaceuticals, LLC.
Jenrin Discovery, Inc.
Johnson & Johnson
JSK Therapeutics Inc.
KAHR medical Ltd.
Keystone Nano, Inc.
Kite Pharma, Inc.
Komipharm International Co., Ltd.
Kowa Company, Ltd.
Les Laboratoires Servier SAS
Ligand Pharmaceuticals, Inc.
LivTech, Inc.
Lixte Biotechnology Holdings, Inc.
Lytix Biopharma AS
MaxCyte, Inc.
MedImmune, LLC
Medivation, Inc.
Medivir AB
Merck KGaA
Merrimack Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc.
Mirna Therapeutics, Inc.
MolMed S.p.A.
MultiCell Technologies, Inc.
NeoPharm Co., Ltd.
Nimbus Therapeutics, LLC
NormOxys, Inc.
Northwest Biotherapeutics, Inc.
Novartis AG
Nymox Pharmaceutical Corporation
Omeros Corporation
Omnitura Therapeutics Inc.
Oncology Research International Limited
Oncolys BioPharma Inc.
OncoMed Pharmaceuticals, Inc.
OncoTherapy Science, Inc.
Oneness Biotech Co., Ltd.
Ono Pharmaceutical Co., Ltd.
Onxeo SA
Onyx Pharmaceuticals, Inc.
OPKO Health, Inc.
Orega Biotech SAS
Otsuka Holdings Co., Ltd.
Panacea Pharmaceuticals, Inc.
Peptinov SAS
Peregrine Pharmaceuticals, Inc.
Pfizer Inc.
Pharma Mar, S.A.
PharmAbcine, Inc.
PharmaEssentia Corporation
PhaseRx, Inc.
Phosplatin Therapeutics LLC
Polaris Pharmaceuticals, Inc.
Progen Pharmaceuticals Limited
ProMetic Life Sciences Inc.
Provecs Medical GmbH
Provectus Biopharmaceuticals, Inc.
Qu Biologics Inc.
Quimatryx, S.L.
Raptor Pharmaceutical Corp.
RedHill Biopharma Ltd.
Regen BioPharma, Inc.
Regulus Therapeutics Inc.
Rigontec GmbH
Saronic Biotechnology, Inc.
Savoy Pharmaceuticals, Inc.
Shenogen Pharma Group Ltd.
Silence Therapeutics Plc
Sillajen Biotherapeutics
Sirnaomics, Inc.
Synovo GmbH
Synta Pharmaceuticals Corp.
Taiwan Liposome Company, Ltd.
Targetome
Therapure Biopharma Inc.
Theravectys SA
Threshold Pharmaceuticals, Inc.
Tiziana
Toko Pharmaceutical Industries Co., Ltd.
TRACON Pharmaceuticals, Inc.
Transgene Biotek Limited
Tumorend, LLC
VasGene Therapeutics, Inc.
Vaxon Biotech
Vect-Horus S.A.S.
Verlyx Pharma Inc.
Vicus Therapeutics, LLC
Virttu Biologics Limited
Viventia Bio Inc.
Welichem Biotech Inc.
Zhejiang BetaPharma Co., Ltd.

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
Global Markets Direct

Our Clients